記事掲載：SLAS2016、薬剤併用による創薬の加速

Select Science
March 22, 2016

Each year the Society for Laboratory Automation and Screening (SLAS) runs a series of Special Interest Groups (SIGs) that allow scientists to meet with peers, to discuss a range of important issues. Drs. Stephan Steigele and Oliver Leven led the inaugural meeting of the SLAS Compound Combination SIG. Dr Leven is the Head of Marketing and Professional Services at Genedata. The company provides software and consulting solutions that support large-scale, experimental processes and automate complex data workflows across a wide range of life sciences industries, including pharmaceutical, biopharmaceutical and academic research organizations. Dr Leven told SelectScience^® about the main topics discussed at this important meeting and the future goals of the SIG.